Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

• Luca Perico,
• Federica Casiraghi,
• Fabiane Sônego,
• Marta Todeschini,
• Daniela Corna,
• Domenico Cerullo,
• Anna Pezzotta,
• Patricia Isnard-Petit,
• Silvia Faravelli,
• Federico Forneris,
• Kader Thiam,
• Ariela Benigni,
• Giuseppe Remuzzi

Affiliations

Luca Perico

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Federica Casiraghi

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Fabiane Sônego

Preclinical Models & Services, genOway, Lyon, France

Marta Todeschini

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Daniela Corna

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Domenico Cerullo

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Anna Pezzotta

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Patricia Isnard-Petit

Preclinical Models & Services, genOway, Lyon, France

Silvia Faravelli

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy

Federico Forneris

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy

Kader Thiam

Preclinical Models & Services, genOway, Lyon, France

Ariela Benigni

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

Giuseppe Remuzzi

Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy